These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells. Plata F, Jongeneel V, Cerottini JC, Brunner KT. Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429 [Abstract] [Full Text] [Related]
3. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro. Ryser JE, Cerottini JC, Brunner KT. Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224 [Abstract] [Full Text] [Related]
4. Suppressor T cells regulate the cytolytic T lymphocyte response to syngeneic tumors induced by murine sarcoma virus (MSV) in the mouse. Plata F, MacDonald HR, Shain B. J Immunol; 1979 Aug; 123(2):852-60. PubMed ID: 156765 [Abstract] [Full Text] [Related]
8. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors. Biasi G, Saggin L, Dazzi F, De Rossi A, Collavo D. J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589 [Abstract] [Full Text] [Related]
10. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice. Kirchner H, Muchmore AV, Chused TM, Holden HT, Herberman RB. J Immunol; 1975 Jan; 114(1 Pt 1):206-10. PubMed ID: 122986 [Abstract] [Full Text] [Related]
11. Generation of cytotoxic T lymphocytes in vitro. VI. Effect of cell density on response in mixed leukocyte cultures. Fitch FW, Engers HD, MacDonald HR, Cerottini JC, Brunner KT. J Immunol; 1975 Dec; 115(6):1688-94. PubMed ID: 127012 [Abstract] [Full Text] [Related]
12. [Functional activity of cytolytic T lymphocytes in the rejection of tumor target cells]. Brunner KT, Cerottini JC. Ann Immunol (Paris); 1977 Dec; 128(1-2):473-83. PubMed ID: 139840 [Abstract] [Full Text] [Related]
13. T cell-mediated immunity to oncornavirus-induced tumors. III. Specific and nonspecific suppression in tumor-bearing mice. Plater C, Debré P, Leclerc JC. Eur J Immunol; 1981 Jan; 11(1):39-44. PubMed ID: 6452278 [Abstract] [Full Text] [Related]
14. T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursor and effector cytolytic T lymphocytes. Leclerc JC, Cantor H. J Immunol; 1980 Feb; 124(2):846-50. PubMed ID: 6243332 [Abstract] [Full Text] [Related]
15. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus. Schenk PJ, Howe ML. J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580 [Abstract] [Full Text] [Related]
16. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection. Jiang D, Flyer DC. J Immunol; 1992 Feb 01; 148(3):974-80. PubMed ID: 1730885 [Abstract] [Full Text] [Related]
17. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier. Collavo D, Parenti A, Biasi G, Chieco-Bianchi L, Colombatti A. J Natl Cancer Inst; 1978 Sep 01; 61(3):885-90. PubMed ID: 80457 [Abstract] [Full Text] [Related]
18. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses. Vallera DA, Mentzer SJ, Maizel SE. Cancer Res; 1982 Feb 01; 42(2):397-404. PubMed ID: 7055792 [Abstract] [Full Text] [Related]
19. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes. Plata F, Jongeneel CV. J Immunol; 1977 Aug 01; 119(2):623-9. PubMed ID: 196025 [No Abstract] [Full Text] [Related]
20. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. Flyer DC, Burakoff SJ, Faller DV. J Immunol; 1985 Oct 01; 135(4):2287-92. PubMed ID: 2411792 [Abstract] [Full Text] [Related] Page: [Next] [New Search]